Elena Meshcheriakova
Overview
Explore the profile of Elena Meshcheriakova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
30
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Farris M, Goodall S, De Abreu Lourenco R, Mulhern B, Manipis K, Meshcheriakova E, et al.
Pharmacoecon Open
. 2024 Aug;
8(6):911-922.
PMID: 39102180
Purpose: Inherited retinal disease (IRD) causes progressive loss of visual function, degenerating towards complete blindness. Economic evaluation of gene therapies for rare forms of genetic IRDs have had to rely...
2.
Kinchin I, Kelley S, Meshcheriakova E, Viney R, Mann J, Thompson F, et al.
Integr Healthc J
. 2023 Jul;
4(1):e000137.
PMID: 37440866
Objective: To assess the cost of implementation, delivery and cost-effectiveness (CE) of a flagship community-based integrated care model (OPEN ARCH) against the usual primary care. Design: A 9-month stepped-wedge cluster-randomised...
3.
Norman R, Robinson S, Dickinson H, Williams I, Meshcheriakova E, Manipis K, et al.
Patient
. 2021 Mar;
14(3):319-330.
PMID: 33660163
Background And Objective: During the COVID-19 pandemic, resources in intensive care units (ICUs) have the potential to be inadequate to treat all those who might benefit. Therefore, it is paramount...
4.
McCarthy M, De Abreu Lourenco R, McMillan L, Meshcheriakova E, Cao A, Gillam L
Patient
. 2020 Feb;
13(3):347-361.
PMID: 32037479
Background: Treatment decision-making in pediatric oncology can be complex. Recent advances in genome sequencing and novel or 'personalized' therapies potentially increases the complexity of decision-making and treatment options. Objectives: This...
5.
Saing S, Haywood P, Van der Linden N, Manipis K, Meshcheriakova E, Goodall S
Appl Health Econ Health Policy
. 2019 Jan;
17(2):243-254.
PMID: 30617458
Background: In 2009, mandatory folic acid fortification of bread-making flour was introduced in Australia to reduce the birth prevalence of preventable neural tube defects (NTDs) such as spina bifida. Before...